February 2025: Revolutionizing Women's Health

Nettle™ by Samphire Neuroscience: A non-invasive, drug-free solution for women's health.

Image: Samphire Neuroscience

We are thrilled to spotlight Nettle™, a groundbreaking wearable device that is transforming women’s health. Developed by Samphire Neuroscience, Nettle™ uses transcranial direct current stimulation (tDCS) to alleviate common menstrual symptoms such as pain, mood swings, and fatigue.

Clinically proven to improve well-being, Nettle™ offers a non-invasive, drug-free alternative to traditional treatments. By gently modulating brain activity, Nettle™ helps women manage their menstrual health more effectively and comfortably. Now available on the market, this innovative device is empowering women to take control of their health with ease.

With its successful launch, Nettle™ is setting a new standard in menstrual health solutions. Experience the future of women’s health today!

About Samphire Neuroscience

Samphire Neuroscience is a pioneering medtech company focused on advancing women’s health through innovative, non-invasive technologies. The company is dedicated to addressing critical health challenges by developing cutting-edge solutions that improve well-being and quality of life. With a strong emphasis on scientific research and technological innovation, Samphire Neuroscience is committed to providing women with safe, effective, and accessible healthcare solutions.

Sam Draper
February 1, 2025

February 2025

Innovation of the Month

Do you want to discover more, visit the website
Visit Website

Other news

InvenSense ICP-10125: Industry’s Lowest Power Waterproof MEMS Barometric Pressure Sensor for Wearables

TDK Corporation’s InvenSense ICP-10125 is part of the InvenSense SmartPressure family of the MEMS...

New Biocompatible Ink for Heart Valve Repair

Biocompatible ink solidifies into different 3D shapes and structures by absorbing ultrasound waves.

August 2025: Ultra-Thin Battery Revolution in Wearables

NGK's 0.45mm EnerCera Battery: Non-Swelling, Non-Flammable Power for Wearables

Wise Therapeutics and Soterix Announce Results of Their Collaborative Study Combining Digital Therapy With Neurostimulation Device

Wise Therapeutics, a developer of game-based digital therapeutics including Personal Zen, and ...
Discover more